Exact Mass: 898.3669

Exact Mass Matches: 898.3669

Found 10 metabolites which its exact mass value is equals to given mass value 898.3669, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

chukvelutilide E

chukvelutilide E

C45H54O19 (898.3259)


   

microsclerodermin G

microsclerodermin G

C45H54N8O12 (898.3861)


   
   
   
   

RO27-3225 (TFA)

RO27-3225 (TFA)

C41H53F3N12O8 (898.4061)


RO27-3225 TFA is potent and selective melanocortin 4 receptor (MC4R) agonist with an EC50 of 1 nM and 8 nM for MC4R and MC1R, respectively. RO27-3225 TFA shows ~30-fold selectivity for MC4R over MC3R. RO27-3225 TFA has neuroprotective and anti-inflammatory effects[1][2][3].

   

9,10-bis(acetyloxy)-21-[(acetyloxy)(furan-3-yl)methyl]-19-(1-hydroxypropylidene)-8,13,21-trimethyl-23-[(2-methylpropanoyl)oxy]-5,18-dioxo-4,12,14,17,24-pentaoxaoctacyclo[11.10.1.1⁸,¹¹.0¹,¹⁵.0²,⁷.0²,¹¹.0¹⁰,¹⁶.0¹⁵,²⁰]pentacosan-22-yl 2-methylpropanoate

9,10-bis(acetyloxy)-21-[(acetyloxy)(furan-3-yl)methyl]-19-(1-hydroxypropylidene)-8,13,21-trimethyl-23-[(2-methylpropanoyl)oxy]-5,18-dioxo-4,12,14,17,24-pentaoxaoctacyclo[11.10.1.1⁸,¹¹.0¹,¹⁵.0²,⁷.0²,¹¹.0¹⁰,¹⁶.0¹⁵,²⁰]pentacosan-22-yl 2-methylpropanoate

C45H54O19 (898.3259)


   

(3ar,6s,7r,11r,18z,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3-methyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethylidene)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one

(3ar,6s,7r,11r,18z,24ar)-7-[(1s,2s,3s,4e,6e,8e)-1,2-dihydroxy-3-methyl-9-phenylnona-4,6,8-trien-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-18-(1h-indol-3-ylmethylidene)-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one

C45H54N8O12 (898.3861)


   

(3ar,6s,7r,11r,18r,24ar)-18-[(6-chloro-1h-indol-3-yl)methyl]-7-[(1s,2s)-1,2-dihydroxy-5-phenylpent-4-en-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-3-methoxy-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one

(3ar,6s,7r,11r,18r,24ar)-18-[(6-chloro-1h-indol-3-yl)methyl]-7-[(1s,2s)-1,2-dihydroxy-5-phenylpent-4-en-1-yl]-2,5,6,9,11,14,17,20,24a-nonahydroxy-3-methoxy-22-methyl-3h,3ah,6h,7h,10h,11h,12h,15h,18h,21h,24h-pyrrolo[2,3-m]1,4,7,10,15,19-hexaazacyclotricosan-23-one

C41H51ClN8O13 (898.3264)


   

(1r,2s,7s,8r,9s,10s,11r,13r,15r,16s,19z,20s,21r,22r,23r)-9,10-bis(acetyloxy)-21-[(s)-(acetyloxy)(furan-3-yl)methyl]-19-(1-hydroxypropylidene)-8,13,21-trimethyl-23-[(2-methylpropanoyl)oxy]-5,18-dioxo-4,12,14,17,24-pentaoxaoctacyclo[11.10.1.1⁸,¹¹.0¹,¹⁵.0²,⁷.0²,¹¹.0¹⁰,¹⁶.0¹⁵,²⁰]pentacosan-22-yl 2-methylpropanoate

(1r,2s,7s,8r,9s,10s,11r,13r,15r,16s,19z,20s,21r,22r,23r)-9,10-bis(acetyloxy)-21-[(s)-(acetyloxy)(furan-3-yl)methyl]-19-(1-hydroxypropylidene)-8,13,21-trimethyl-23-[(2-methylpropanoyl)oxy]-5,18-dioxo-4,12,14,17,24-pentaoxaoctacyclo[11.10.1.1⁸,¹¹.0¹,¹⁵.0²,⁷.0²,¹¹.0¹⁰,¹⁶.0¹⁵,²⁰]pentacosan-22-yl 2-methylpropanoate

C45H54O19 (898.3259)